Key points are not available for this paper at this time.
Further studies will warrant possible applications of curcuminoids as therapeutic BACE-1 blockers.
Wang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: